What is appropriate neoadjuvant/adjuvant androgen deprivation for high-risk/locally advanced prostate cancer?

被引：3
|
作者：
Namiki, Mikio [1 ]
Konaka, Hiroyuki [1 ]
机构：
[1] Kanazawa Univ, Grad Sch Med Sci, Dept Integrat Canc Therapy & Urol, Kanazawa, Ishikawa 9208640, Japan
来源：
ASIAN JOURNAL OF ANDROLOGY | 2011年 / 13卷 / 04期
关键词：
RADIATION-THERAPY; RADICAL PROSTATECTOMY; BRACHYTHERAPY; DURATION; TRIAL;
D O I：
10.1038/aja.2011.74
中图分类号：
R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：624 / 625
页数：2
相关论文
共 50 条
  • [1] Androgen deprivation therapy as adjuvant/neoadjuvant to radiotherapy for high-risk localised and locally advanced prostate cancer: recent developments
    H Payne
    M Mason
    [J]. British Journal of Cancer, 2011, 105 : 1628 - 1634
  • [2] Androgen deprivation therapy as adjuvant/neoadjuvant to radiotherapy for high-risk localised and locally advanced prostate cancer: recent developments
    Payne, H.
    Mason, M.
    [J]. BRITISH JOURNAL OF CANCER, 2011, 105 (11) : 1628 - 1634
  • [3] Androgen Deprivation Therapy in High-Risk Localized and Locally Advanced Prostate Cancer
    Iwamoto, Hiroaki
    Izumi, Kouji
    Makino, Tomoyuki
    Mizokami, Atsushi
    [J]. CANCERS, 2022, 14 (07)
  • [4] High-risk prostate cancer: is androgen deprivation monotherapy still appropriate?
    Shahinian, Vahakn B.
    [J]. ASIAN JOURNAL OF ANDROLOGY, 2012, 14 (03) : 419 - 420
  • [5] Neoadjuvant radiotherapy for locally advanced and high-risk prostate cancer
    John Thoms
    Jayant S. Goda
    Alexender R. Zlotta
    Neil E. Fleshner
    Theodorus H. van der Kwast
    Stéphane Supiot
    Padraig Warde
    Robert G. Bristow
    [J]. Nature Reviews Clinical Oncology, 2011, 8 : 107 - 113
  • [6] Neoadjuvant radiotherapy for locally advanced and high-risk prostate cancer
    Thoms, John
    Goda, Jayant S.
    Zlotta, Alexendre R.
    Fleshner, Neil E.
    van der Kwast, Theodorus H.
    Supiot, St Phane
    Warde, Padraig
    Bristow, Robert G.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2011, 8 (02) : 107 - 113
  • [7] Androgen deprivation adjuvant to definitive radiotherapy in locally advanced prostate cancer
    Bottke, D
    Wiegel, T
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 (05) : 290 - 291
  • [8] Androgen Deprivation Therapy in High-Risk Prostate Cancer
    Buyyounouski, Mark K.
    [J]. ONCOLOGY-NEW YORK, 2010, 24 (09): : 806 - 809
  • [9] Neoadjuvant docetaxel and estramustine chemotherapy in high-risk/locally advanced prostate cancer
    Hussain, M
    Smith, DC
    El-Rayes, BF
    Du, W
    Vaishampayan, U
    Fontana, J
    Sakr, W
    Wood, D
    [J]. UROLOGY, 2003, 61 (04) : 774 - 780
  • [10] Neoadjuvant and adjuvant treatment in high-risk prostate cancer
    Bandini, Marco
    Fossati, Nicola
    Gandaglia, Giorgio
    Preisser, Felix
    Dell'Oglio, Paolo
    Zaffuto, Emanuele
    Stabile, Armando
    Gallina, Andrea
    Suardi, Nazareno
    Shariat, Shahrokh F.
    Montorsi, Francesco
    Karakiewicz, Pierre I.
    Briganti, Alberto
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2018, 11 (04) : 425 - 438
12345